Search - tctmd.com

Displaying 421 - 440 of 1013

Sort: Relevancy | Date

News Daily News

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

November 24, 2021

COVID-19: TCTMD’s Dispatch for November Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 4

November 22, 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

November 18, 2021

ESC Releases Guidance on How to Address CVD in COVID-19 Era

News Daily News

ESC Releases Guidance on How to Address CVD in COVID-19 Era

Yael L. Maxwell

November 17, 2021

Rox Heart Radio: Clinical Trials in the Time of Pandemic

Podcast Rox Heart Radio

Rox Heart Radio: Clinical Trials in the Time of Pandemic

November 17, 2021

Canagliflozin Improves Quality of Life in HF Patients

News Conference News AHA 2021

Canagliflozin Improves Quality of Life in HF Patients

Michael O'Riordan

November 16, 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

November 15, 2021

COVID-19: TCTMD’s Dispatch for November Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 3

November 15, 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

News Conference News AHA 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

Yael L. Maxwell

November 14, 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

News Conference News AHA 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Michael O'Riordan

November 13, 2021

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

News Conference News TCT 2021

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

November 11, 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 08, 2021

COVID-19: TCTMD’s Dispatch for November Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 2

November 08, 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

Successful Percutaneous Mechanical Thrombectomy After Failure of Systemic Thrombolytics to Treat Intermediate-High-Risk Bilateral Pulmonary Embolism in a COVID-19 Patient

Presentation TCT 2021

Successful Percutaneous Mechanical Thrombectomy After Failure of Systemic Thrombolytics to Treat Intermediate-High-Risk Bilateral Pulmonary Embolism in a COVID-19 Patient

Presenter: Samy Selim

November 05, 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

November 05, 2021

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

News Conference News TCT 2021

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

November 04, 2021

Myocarditis After Covid-19 Vaccination: What Clinicians Need to Know

Presentation TCT 2021

Myocarditis After Covid-19 Vaccination: What Clinicians Need to Know

Presenter: Guy Witberg

November 04, 2021

Impact of the COVID-19 Pandemic on FDA: Review of Changes and Looking Ahead

Presentation TCT 2021

Impact of the COVID-19 Pandemic on FDA: Review of Changes and Looking Ahead

Presenter: William Maisel

November 04, 2021

TCT 688: Coil embolization for an iatrogenic radial artery pseudoaneurysm in a patient with COVID-19

Presentation TCT 2021

TCT 688: Coil embolization for an iatrogenic radial artery pseudoaneurysm in a patient with COVID-19

Presenter: Soichiro Washimi

November 04, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.